[1] Sun X, Ou Z, Chen R, et al.Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells[J]. Hepatology, 2016, 63(1): 173-184.
[2] Dolma S, Lessnick SL, Hahn WC, et al.Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell, 2003, 3(3): 285-296.
[3] Seiler A, Schneider M, Förster H, et al.Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death[J]. Cell Metab, 2008, 8(3): 237-248.
[4] Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331.
[5] Jiang L, Kon N, Li T, et al.Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015,520(7545): 57-62.
[6] Sun WY, Wang R, He RR.LC-MS-based redox phosphoipidomics analysis in ferroptosis[J]. Methods Mol Biol, 2023, 2712: 81-90.
[7] Qiu B, Zandkarimi F, Bezjian CT, et al.Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis[J]. Cell, 2024, 187(5): 1177-1190.
[8] Yang WS, Stockwell BR.Ferroptosis: death by lipid peroxidation[J]. Trends Cell Biol, 2016, 26(3): 165-176.
[9] Bersuker K, Hendricks JM, Li Z, et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature, 2019, 575(7784): 688-692.
[10] Ding CC, Rose J, Sun T, et al.MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis[J]. Nat Metab, 2020, 2(3): 270-277.
[11] Mao C, Liu X, Zhang Y, et al.DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J]. Nature, 2021, 593(7860): 586-590.
[12] Kraft VAN, Bezjian CT, Pfeiffer S, et al.GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J]. ACS Cent Sci, 2020, 6(1): 41-53.
[13] Lee J, You JH, Roh JL.Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer[J]. Redox Biol, 2022, 51: 102276.
[14] Wenzel SE, Tyurina YY, Zhao J, et al.PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals[J]. Cell, 2017, 171(3): 628-641.
[15] Manivarma T, Kapralov AA, Samovich SN, et al.Membrane regulation of 15LOX-1/PEBP1 complex prompts the generation of ferroptotic signals, oxygenated PEs[J]. Free Radic Biol Med, 2023, 208: 458-467.
[16] Zou Y, Li H, Graham ET, et al.Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J].Nat Chem Biol, 2021, 17(4): 501.
[17] Polewski MD, Reveron-Thornton RF, Cherryholmes GA, et al.Increased expression of system xc- in glioblastoma confers an altered metabolic state and temozolomide resistance[J]. Mol Cancer Res, 2016, 14(12): 1229-1242.
[18] Polewski MD, Reveron-Thornton RF, Cherryholmes GA, et al.SLC7A11 overexpression in glioblastoma is associated with increased cancer stem cell-like properties[J]. Stem Cells, 2017, 26(17): 1236-1246.
[19] Yang X, Liu J, Wang C, et al.miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities[J]. Oncogenesis, 2021, 10(2): 15.
[20] Huang C, Yang M, Deng J,et al.Upregulation and activation of p53 by erastin-induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells[J]. Oncol Rep, 2018, 40(4): 2363-2370.
[21] Hu K, Li K, Lv J, et al.Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma[J]. J Clin Invest, 2020, 130(4): 1752-1766.
[22] Ma Z, Zhang H, Lian M, et al.SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma[J]. Oncol Rep, 2017, 38(5): 3019-3029.
[23] Egolf S, Zou J, Anderson A, et al. MLL4 mediates differentiation and tumor suppression through ferroptosis[J]. Sci Adv, 2021, 7(50): eabj9141.
[24] Tang R, Hua J, Xu J, et al.The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer[J]. Ann Transl Med, 2020, 8(21): 1347.
[25] Bolli E, O'Rourke JP, Conti L, et al. A virus-like-particle immunotherapy targeting epitope-specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo[J]. Oncoimmunology, 2017, 7(3): e1408746.
[26] Liao P, Wang W, Wang W, et al.CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4[J]. Cancer Cell, 2022, 40(4): 365-378.
[27] Ubellacker JM, Tasdogan A, Ramesh V, et al.Lymph protects metastasizing melanoma cells from ferroptosis[J]. Nature, 2020, 585(7823): 113-118.
[28] Lin H, Tison K, Du Y, et al.Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance[J]. Cancer Cell, 2024, 42(12): 2032-2044.
[29] Lv H, Zhen C, Liu J,et al.β-Phenethyl isothiocyanate induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the MAPK signaling pathway[J]. Oxid Med Cell Longev, 2020,2020: 5021983.
[30] Jiwa H, Xie Z, Qu X, et al.Casticin induces ferroptosis in human osteosarcoma cells through Fe2+ overload and ROS production mediated by HMOX1 and LC3-NCOA4[J]. Biochem Pharmacol, 2024, 226: 116346.
[31] Chen W, Li Z, Yu N, et al.Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells[J]. J Nanobiotechnology, 2023, 21(1): 355.
[32] Zeng X, Lin GX, Zeng X, et al.Penfluridol regulates p62 / Keap1 /Nrf2 signaling pathway to induce ferroptosis in osteosarcoma cells[J]. Biomed Pharmacother, 2024, 177: 117094.
[33] Luo Y, Gao X, Zou L, et al.Bavachin induces ferroptosis through the STAT3/P53/SLC7A11 axis in osteosarcoma cells[J]. Oxid Med Cell Longev, 2021, 2021: 1783485.
[34] Li X, Liu J.FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma[J]. BMC Cancer, 2023, 23(1): 179.
[35] Panczyszyn E, Saverio V, Monzani R, et al.FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target[J]. Cell Death Discov, 2024, 10(1): 87.
[36] Yuan Y, Mei Z, Qu Z, et al.Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure[J]. Signal Transduct Target Ther, 2023,8(1): 121.
[37] Luo SH, Tian JM, Chu Y, et al.The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells[J]. Cell Death Dis, 2023, 14(11): 760.
[38] Yang L, Liu J, Liu S.Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma[J]. BMC Cancer, 2023, 23(1): 229.
[39] Zhu Y, Yang L, Yu Y, et al.Hydroxysafflor yellow A induced ferroptosis of osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway[J]. Oncol Res, 2024, 32(5): 899-910.
[40] Xu WN, Yang RZ, Zheng HL,et al.NDUFA4L2 regulated by HIF-1α promotes metastasis and epithelial-mesenchymal transition of osteosarcoma cells through inhibiting ROS production[J]. Front Cell DevBiol, 2020, 8: 515051.
[41] Jiang M, Jike Y, Liu K, et al.Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1[J]. Mol Cancer. 2023, 22(1): 113.
[42] Ma J, Guo Z, Yang X, et al.Exploration of various roles of hypoxia genes in osteosarcoma[J]. Sci Rep, 2022, 12(1): 18293.
[43] Zheng D, Xia K, Wei Z, et al.Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma[J]. Front Genet, 2022, 13: 944978.
[44] Lv Z, Yang D, Li J, et al.Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion[J]. Mol Cells, 2013, 36(2): 119-126.
[45] Chen M, Jiang Y, Sun Y.KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma[J]. Biochem Biophys Res Commun, 2021, 550: 77-83.
[46] Meazza C, Scanagatta P.Metastatic osteosarcoma: a challenging multidisciplinary treatment[J]. Expert Rev Anticancer Ther, 2016, 16(5): 543-556.
[47] Wang D, Song Z, Wang Z.Common mechanism of pathogenesis in various types of metastatic osteosarcoma[J]. Oncol Lett, 2017, 14(5): 6307-6313.
[48] Zhan F, He T, Chen Z, et al.RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway[J]. Cell Biosci,2021, 11(1): 179.
[49] Zhan F, Zhang Y, Zuo Q, et al.YAP knockdown in combination with ferroptosis induction increases the sensitivity of HOS human osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy[J]. Photodiagnosis Photodyn Ther, 2022, 39: 102964.
[50] Fu J, Li T, Yang Y, et al.Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors[J]. Biomaterials, 2021, 268: 120537.
